Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTX-2001 in Alcohol Use Disorder
NCT07520292Phase 1Recruiting
- Sponsor
- Newleos Therapeutics
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing NTX-2001 with Placebo (2 arms). Primary endpoint: Number of drinks consumed during the alcohol drinking paradigm (ADP). Started Mar 2026; status: recruiting.
02
Drugs
RO7308480
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07520292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07520292.